Bone graft substitutes in active or suspected infection. Contra-indicated or not?

Jan Geurts*, J. J. Chris Arts, G. H. I. M. Walenkamp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

42 Citations (Web of Science)

Abstract

Treatment of infection in clinical orthopaedic and trauma care is a time consuming and costly endeavour. More than once, it will lead to extraction of implant material and additional surgical interventions. Currently, debridement, implantation of PMMA beads impregnated with antibiotics most often with implant exchange are the gold standard for deep infection treatment. Recently bone graft substitute materials such as calcium phosphate, collagen fleeces and bioglasses have appeared for specific use in infection treatment. Although these materials show great potential, their supporting level of evidence is still limited. This review paper provides an overview of current understanding and therapies for infection treatment and provides concepts for the use of new developed biomaterials in infection treatment. Furthermore, the benefits and risks of using biomaterials in infection treatment are discussed and the level of evidence of a number of new materials is presented.
Original languageEnglish
Pages (from-to)S82-S86
JournalInjury-International Journal of the Care of the Injured
Volume42
DOIs
Publication statusPublished - Sep 2011

Keywords

  • Arthroplasty
  • Infection
  • Clinical outcome
  • Bone graft substitute
  • Antibiotics

Cite this